SARS-CoV-2 - Primary antibodies for research and development
The current COVID-19 pandemic has sickened more than 520,000 people worldwide and continues to increase daily. There is an urgent need to increase current diagnostic capacity. Compared to the commonly used PCR test, the diagnostic method based on the serological test is much easier and faster to perform. To support the development of immunodiagnostic methods, we offer a comprehensive collection of antibodies and antigens for SARS-CoV-2.
We offer a full range of antibodies directed against the major proteins of SARS-CoV-2 to detect antigens on the surface of the SARS-CoV-2 virus (or recombinant antigens). These antibodies can be useful for SARS-CoV-2 research or for the development of new immunological tests.
The main antigens of SARS-CoV-2 are the nucleocapsid protein (N protein), which is the most abundant protein in coronaviruses and highly immunogenic, and the Spike protein (S protein).